Home Newsletters Hematopoiesis News Predicting the Loss of Hepatitis B Surface Antigen Following Hematopoietic Stem Cell...

Predicting the Loss of Hepatitis B Surface Antigen Following Hematopoietic Stem Cell Transplantation in Patients with Chronic HBV Infection

By
Jamie Kang
-
0
A total of 62 patients with chronic hepatitis B virus infection achieved hepatitis B surface antigen (HBsAg) loss after allogeneic hematopoietic stem cell transplantation (allo-HSCT).
[Bone Marrow Transplantation]
Abstract

RELATED ARTICLES

Exit mobile version